The use of ex vivo T-cell depletion, with CD34+ selection (69), CD3/CD19 depletion (70), or T-cell receptor (TCR) α/β and CD19 depletion (71), has also been reported in haploidentical HCT for SCD. This evidence concerns the gene CD19 and Schnyder corneal dystrophy.